BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30516669)

  • 1. Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma.
    Fu Z; Chen X; Yang X; Li Q
    Clin Nucl Med; 2019 Feb; 44(2):169-170. PubMed ID: 30516669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
    Xu F; Liu F; Pastakia B
    Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging.
    Bhutani M; Turkbey B; Tan E; Korde N; Kwok M; Manasanch EE; Tageja N; Mailankody S; Roschewski M; Mulquin M; Carpenter A; Lamping E; Minter AR; Weiss BM; Mena E; Lindenberg L; Calvo KR; Maric I; Usmani SZ; Choyke PL; Kurdziel K; Landgren O
    Leuk Lymphoma; 2016 May; 57(5):1114-21. PubMed ID: 26690712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.
    Pan Q; Luo Y; Cao X; Ma Y; Li F
    Clin Nucl Med; 2018 Jun; 43(6):462-463. PubMed ID: 29538035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for a Quantitative
    Takahashi MES; Mosci C; Souza EM; Brunetto SQ; Etchebehere E; Santos AO; Camacho MR; Miranda E; Lima MCL; Amorim BJ; de Souza C; Pericole FV; Lorand-Metze I; Ramos CD
    Sci Rep; 2019 Nov; 9(1):16429. PubMed ID: 31712729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Skeletal Superscan on 18F-FDG PET/CT in a Case of Acute Lymphoblastic Leukemia.
    Parida GK; Soundararajan R; Passah A; Bal C; Kumar R
    Clin Nucl Med; 2015 Jul; 40(7):567-8. PubMed ID: 26018718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.
    Takahashi MES; Mosci C; Souza EM; Brunetto SQ; de Souza C; Pericole FV; Lorand-Metze I; Ramos CD
    Nucl Med Commun; 2020 Apr; 41(4):377-382. PubMed ID: 32058446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Infiltration of Multiple Myeloma With Initial Manifestation of Cavernous Sinus Syndrome Unveiled by 18F-FDG PET/CT.
    Li C; Shao F; Yang Y; Lan X
    Clin Nucl Med; 2019 Sep; 44(9):746-747. PubMed ID: 31306198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Myeloma of Testes and Spermatic Cord on 18F-FDG PET/CT.
    Velaga J; Liang HH; Gopalakrishnan SK
    Clin Nucl Med; 2019 Apr; 44(4):297-298. PubMed ID: 30688733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma.
    Causa Andrieu PI; Das JP; Woo S; Ryan R; Akin O; Ulaner GA
    Clin Nucl Med; 2020 Nov; 45(11):873-875. PubMed ID: 32657873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET in the evaluation of myeloma in 2012.
    Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
    Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
    Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Hyperparathyroidism.
    Mohd Rohani MF; Bujang NL; Rosdi AH; Amir Hassan SZ
    Clin Nucl Med; 2024 Jan; 49(1):e19-e21. PubMed ID: 37883221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.